The Scientist

» anxiety and disease/medicine

Most Recent

A needle-free alternative to the finger-prick test would be a godsend for many sufferers of diabetes, but the industry has yet to clear the technological hurdles.

1 Comment

Spark Therapeutics’s Luxturna would be the first approved therapy in the U.S. that replaces or repairs a defective gene inherited from one’s parents.

3 Comments

Combined transcription and genome data from multiple tissues in hundreds of human donors reveal links between genotype and gene expression across the body.

1 Comment

Tissue recipients were treated as “guinea pigs,” says investigation leader.

0 Comments

Mice receiving the treatment produced their own monoclonal antibodies and survived infection with the life-threatening pathogen Pseudomonas aeruginosa.

2 Comments

image: Giants of Circadian Biology Win Nobel Prize

Giants of Circadian Biology Win Nobel Prize

By | October 2, 2017

The award in Physiology or Medicine goes to chronobiologists Jeffrey Hall, Michael Rosbash, and Michael Young.

1 Comment

image: Bathtub Bloodbath, 1793

Bathtub Bloodbath, 1793

By | October 1, 2017

French revolutionary Jean-Paul Marat took on many roles over the course of his life, including physician and scientist.

0 Comments

Researchers suggest that the receptors can control early labor contractions.

0 Comments

image: Contributors

Contributors

By | October 1, 2017

Meet some of the people featured in the October 2017 issue of The Scientist.

0 Comments

image: Drugging the Disorderome

Drugging the Disorderome

By | October 1, 2017

Strategies for targeting intrinsically disordered proteins

0 Comments

Popular Now

  1. Man Receives First In Vivo Gene-Editing Therapy
  2. Researchers Build a Cancer Immunotherapy Without Immune Cells
  3. Long-term Study Finds That the Pesticide Glyphosate Does Not Cause Cancer
  4. Research Links Gut Health to Neurodegeneration
    The Nutshell Research Links Gut Health to Neurodegeneration

    Rodent studies presented at the Society for Neuroscience meeting this week tie pathologies in the gastrointestinal tract or microbiome composition with Parkinson’s and Alzheimer’s diseases.

RayBiotech